Boothbay Fund Management »

Crinetics Pharmaceuticals In shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.6M 109k 51.10
2024-06-30 $6.8M 151k 44.79
2024-03-31 $12M 250k 46.81
2023-09-30 $10M 344k 29.74
2023-06-30 $1.7M 97k 18.02
2020-06-30 $208k 12k 17.55

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dell Technologies CL C Call Option (DELL)
Select Sector Spdr Tr Indl Put Option (XLI)
Cornerstone Strategic Value (CLM)
NVIDIA Corporation Put Option (NVDA)
Take-Two Interactive Software (TTWO)
Sba Communications Corp Cl A (SBAC)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Netflix (NFLX)
Vertex Pharmaceuticals Incorporated Call Option (VRTX)
Elanco Animal Health Call Option (ELAN)
Amphenol Corp Cl A (APH)
Western Digital Call Option (WDC)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Equinix (EQIX)

View all positions for Boothbay Fund Management

Top funds holding Crinetics Pharmaceuticals In

BlackRock
Vanguard Group
Driehaus Capital Management
T. Rowe Price Associates
Wellington Management Company
FMR
EcoR1 Capital
State Street Corporation
Jennison Associates
Paradigm Biocapital Advisors
Henderson Group
Point72 Asset Management
Geode Capital Management
Franklin Resources
Siren

View all funds holding Crinetics Pharmaceuticals In